OXA-01
Modify Date: 2024-02-05 16:07:32
OXA-01 structure
|
Common Name | OXA-01 | ||
|---|---|---|---|---|
| CAS Number | 936889-68-8 | Molecular Weight | 409.86900 | |
| Density | 1.61±0.1 g/cm3 (20 °C, 760 mmHg) | Boiling Point | N/A | |
| Molecular Formula | C21H20ClN5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OXA-01OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC50 values of 29 nM and 7 nM, respectively[1]. |
| Name | Cyclohexanecarboxylic acid, 4-[8-amino-1-(7-chloro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-, trans |
|---|
| Description | OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC50 values of 29 nM and 7 nM, respectively[1]. |
|---|---|
| Related Catalog | |
| In Vivo | OXA-01 demonstrated broad anti-tumor activity in several different human xenograft models of various histologies. Furthermore, in GEO and Colo-205 colon xenograft models, OXA-01 demonstrated 100% TGI, whilst rapamycin treatment resulted in only 75% and 53% TGI, respectively[1]. |
| References |
[1]. OXA-01 displays improved anti-tumor activity in comparison to Rapamycin. |
| Density | 1.61±0.1 g/cm3 (20 °C, 760 mmHg) |
|---|---|
| Molecular Formula | C21H20ClN5O2 |
| Molecular Weight | 409.86900 |
| Exact Mass | 409.13100 |
| PSA | 109.30000 |
| LogP | 5.05280 |